Fact CheckerSign in

NCT07261813Not yet recruiting

Chronic Obstructive Pulmonary Disease, Quality of Life, COPD Assessment Test, Nepal, Dyspnea, Spirometry

Source: ClinicalTrials.gov · Last updated 3 Dec 2025

Brief summary (registry, in English)

Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation that is not fully reversible. The study "Quality of life among people living with Chronic Obstructive Pulmonary Disease- visiting spirometry center of Tribhuvan University Teaching Hospital, Kathmandu Nepal" aims to assess the quality of life (QOL) of COPD patients and the factors affecting it. A cross sectional study will be performed among the patients visiting Spirometry center of Tribhuvan University Teaching Hospital, Kathmandu Nepal using Convenience Sampling. Ethical approval will be obtained from Institutional Review Board (IRB) of TUTH and written/verbal consent for data collection will be obtained from Teaching hospital authority as well as the respondents. CAT questionnaire will be used to assess quality of life and the Medical Research Council questionnaire will be used to assess the severity of dyspnea. Data management and analysis will be conducted through Statistical Package for Social Sciences (SPSS) version 26.0.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
71 (estimated)
First submitted
14 Nov 2025
Start date
1 Dec 2025
Primary completion date
1 Jan 2026
Lead sponsor
Institute of medicine, Maharagjung medical campus
Diseases
COPD
NCT number
NCT07261813

What you commit to

  • Study type: Observational
  • Planned participants: 71
  • From 1 Dec 2025 to the primary completion date, 1 Jan 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of significant respiratory diseases that can confound COPD assessment (e.g., asthma, bronchiectasis, active tuberculosis)

Other

  • Unable to perform acceptable spirometry maneuvers

Who the study is looking for

  • Age ≥ 20 years
  • Referred to the spirometry center of Tribhuvan University Teaching Hospital
  • Confirmed diagnosis of COPD based on GOLD criteria: post-bronchodilator FEV1/FVC \< 0.7

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.